The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse

doi:10.1038/leu.2015.62

. 2015 Sep;29(9):1952-4.

doi: 10.1038/leu.2015.62. Epub 2015 Mar 9.

The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse

S J Coles^{1

2}, M N Gilmour², R Reid², S Knapper², A K Burnett², S Man², A Tonks², R L Darley²

Affiliations

¹ Institute of Science and the Environment, University of Worcester, Worcester, UK.
² Department of Haematology, Institute of Cancer and Genetics, School of Medicine, Cardiff University, Wales, UK.

PMID: 25748687
DOI: 10.1038/leu.2015.62

The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse

S J Coles et al. Leukemia. 2015 Sep.

. 2015 Sep;29(9):1952-4.

doi: 10.1038/leu.2015.62. Epub 2015 Mar 9.

Authors

S J Coles^{1

2}, M N Gilmour², R Reid², S Knapper², A K Burnett², S Man², A Tonks², R L Darley²

Affiliations

¹ Institute of Science and the Environment, University of Worcester, Worcester, UK.
² Department of Haematology, Institute of Cancer and Genetics, School of Medicine, Cardiff University, Wales, UK.

PMID: 25748687
DOI: 10.1038/leu.2015.62

No abstract available

PubMed Disclaimer

Cited by

CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via β-Catenin-Mediated Nuclear Translocation.
Shin SP, Goh AR, Kang HG, Kim SJ, Kim JK, Kim KT, Lee JH, Bae YS, Jung YS, Lee SJ. Shin SP, et al. Cancers (Basel). 2019 Oct 17;11(10):1583. doi: 10.3390/cancers11101583. Cancers (Basel). 2019. PMID: 31627350 Free PMC article.
Checkpoint Inhibitors in Acute Myeloid Leukemia.
Damiani D, Tiribelli M. Damiani D, et al. Biomedicines. 2023 Jun 15;11(6):1724. doi: 10.3390/biomedicines11061724. Biomedicines. 2023. PMID: 37371818 Free PMC article. Review.
Present and Future Role of Immune Targets in Acute Myeloid Leukemia.
Damiani D, Tiribelli M. Damiani D, et al. Cancers (Basel). 2022 Dec 30;15(1):253. doi: 10.3390/cancers15010253. Cancers (Basel). 2022. PMID: 36612249 Free PMC article. Review.
The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia.
Zeng T, Cui L, Huang W, Liu Y, Si C, Qian T, Deng C, Fu L. Zeng T, et al. BMC Med. 2021 Aug 5;19(1):176. doi: 10.1186/s12916-021-02047-9. BMC Med. 2021. PMID: 34348737 Free PMC article.
Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.
An G, Acharya C, Feng X, Wen K, Zhong M, Zhang L, Munshi NC, Qiu L, Tai YT, Anderson KC. An G, et al. Blood. 2016 Sep 22;128(12):1590-603. doi: 10.1182/blood-2016-03-707547. Epub 2016 Jul 14. Blood. 2016. PMID: 27418644 Free PMC article.

See all "Cited by" articles

References

1. Leukemia. 2011 May;25(5):792-9 - PubMed
1. Leukemia. 2007 Mar;21(3):566-8 - PubMed
1. Br J Haematol. 2013 Aug;162(4):509-16 - PubMed
1. Clin Cancer Res. 2009 Aug 1;15(15):4944-53 - PubMed
1. J Transl Med. 2013 Feb 12;11:37 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

[1] Leukemia. 2011 May;25(5):792-9 - PubMed

[2] Leukemia. 2011 May;25(5):792-9 - PubMed

[3] Leukemia. 2007 Mar;21(3):566-8 - PubMed

[4] Leukemia. 2007 Mar;21(3):566-8 - PubMed

[5] Br J Haematol. 2013 Aug;162(4):509-16 - PubMed

[6] Br J Haematol. 2013 Aug;162(4):509-16 - PubMed

[7] Clin Cancer Res. 2009 Aug 1;15(15):4944-53 - PubMed

[8] Clin Cancer Res. 2009 Aug 1;15(15):4944-53 - PubMed

[9] J Transl Med. 2013 Feb 12;11:37 - PubMed

[10] J Transl Med. 2013 Feb 12;11:37 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse

Affiliations

The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials